CARAWAY
Live / Applied — Third extension granted (statement of use) (as of 03 Dec 2025)
What this means for you
Not registered yet, but its 22 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98145031
- Mark type
- Stylized text
- Filed
- 22 Aug 2023
- Published for opposition
- 28 May 2024
- Attorney of record
- Alexandra M. Vaccaro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic preparations for the treatment of rare neurodegenerative diseases and neurodegenerative diseases
Owner
- Caraway Therapeutics, Inc., Rahway, NJ, US
- Caraway Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 03 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 3 GRANTED
- 03 Dec 2025 — SOU EXTENSION 3 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — SOU EXTENSION 2 GRANTED
- 27 Jun 2025 — SOU EXTENSION 2 FILED
- 27 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2025 — SOU EXTENSION 1 GRANTED
- 07 Jan 2025 — SOU EXTENSION 1 FILED
- 07 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION